STOCKWATCH
·
Medical Specialities
Quarterly ResultMay 12, 2026, 04:09 PM

Lumexa Imaging Q1 Revenue +3.1% to $252.5M; Net Income $1.7M

AI Summary

Lumexa Imaging reported its first quarter 2026 results, with consolidated revenues increasing 3.1% to $252.5 million and net income reaching $1.7 million, a significant improvement from a net loss of $7.7 million in the prior year. The company also announced the addition of four new imaging centers, including two strategic acquisitions and two de novo centers, progressing towards its goal of 8-10 de novos this year. Lumexa Imaging reiterated its full-year 2026 guidance for consolidated revenues and Adjusted EBITDA, expressing confidence in sustained profitable growth.

Key Highlights

  • Consolidated revenues increased 3.1% to $252.5 million in Q1 2026 from $245.0 million in Q1 2025.
  • Net income was $1.7 million in Q1 2026, compared to a net loss of $7.7 million in Q1 2025.
  • Adjusted EBITDA was $51.2 million, up from $51.0 million, with a 20.3% Adjusted EBITDA margin.
  • GAAP EPS was $0.02 per share, and Adjusted EPS was $0.18 per share.
  • Same-center advanced imaging volume grew 5.6% for both consolidated and system-wide operations.
  • Company announced four new centers, including two strategic tuck-in acquisitions and two de novos.
  • Reiterated full-year 2026 guidance: consolidated revenues $1.045B-$1.097B and Adjusted EBITDA $234M-$242M.
LMRI
Medical Specialities
Lumexa Imaging Holdings, Inc.

Price Impact